These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7751968)

  • 1. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.
    Sulzer D; Chen TK; Lau YY; Kristensen H; Rayport S; Ewing A
    J Neurosci; 1995 May; 15(5 Pt 2):4102-8. PubMed ID: 7751968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.
    Hondebrink L; Meulenbelt J; Timmerman JG; van den Berg M; Westerink RH
    J Neurochem; 2009 Oct; 111(2):624-33. PubMed ID: 19702656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine inhibits amphetamine action in ventral midbrain culture.
    Sulzer D; St Remy C; Rayport S
    Mol Pharmacol; 1996 Feb; 49(2):338-42. PubMed ID: 8632767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple classes of catecholamine vesicles observed during exocytosis from the Planorbis cell body.
    Chen G; Ewing AG
    Brain Res; 1995 Dec; 701(1-2):167-74. PubMed ID: 8925280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
    Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
    J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which amphetamine redistributes dopamine out of vesicles: a computational study.
    Wallace LJ; Connell LE
    Synapse; 2008 May; 62(5):370-8. PubMed ID: 18297690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
    Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
    Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.
    Tucker KR; Block ER; Levitan ES
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4485-94. PubMed ID: 26216995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
    Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles.
    Schwartz K; Weizman A; Rehavi M
    J Neural Transm (Vienna); 2006 Sep; 113(9):1347-52. PubMed ID: 16362637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):261-9. PubMed ID: 2477260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine levels of two classes of vesicles are differentially depleted by amphetamine.
    Anderson BB; Chen G; Gutman DA; Ewing AG
    Brain Res; 1998 Mar; 788(1-2):294-301. PubMed ID: 9555063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro.
    Pothos E; Desmond M; Sulzer D
    J Neurochem; 1996 Feb; 66(2):629-36. PubMed ID: 8592133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of dopamine quantal size in midbrain and hippocampal neurons.
    Pothos EN
    Behav Brain Res; 2002 Mar; 130(1-2):203-7. PubMed ID: 11864736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.
    Pothos EN; Larsen KE; Krantz DE; Liu Y; Haycock JW; Setlik W; Gershon MD; Edwards RH; Sulzer D
    J Neurosci; 2000 Oct; 20(19):7297-306. PubMed ID: 11007887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.
    Sulzer D; Maidment NT; Rayport S
    J Neurochem; 1993 Feb; 60(2):527-35. PubMed ID: 8419534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles.
    Kantor L; Hewlett GH; Gnegy ME
    J Neurosci; 1999 May; 19(10):3801-8. PubMed ID: 10234012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW; Bradberry CW; Moghaddam B
    Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemical detection of reverse transport from Planorbis giant dopamine neuron.
    Anderson BB; Ewing AG; Sulzer D
    Methods Enzymol; 1998; 296():675-89. PubMed ID: 9779482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.